Residency · Lebanon, NH
Sponsored by Dartmouth-Hitchcock/Mary Hitchcock Memorial Hospital
Updated classification of epileptic seizures: Position paper of the International League Against Epilepsy.
Epilepsia · 2025 · 307 citations · Barbara Jobst
Vorasidenib in IDH1- or IDH2-Mutant Low-Grade Glioma.
The New England journal of medicine · 2023 · 643 citations · Yoshie Umemura
A fluid biomarker reveals loss of TDP-43 splicing repression in presymptomatic ALS-FTD.
Nature medicine · 2024 · 142 citations · Mark Garret
Therapeutic Targets in Glioblastoma: Molecular Pathways, Emerging Strategies, and Future Directions.
Cells · 2025 · 51 citations · Nishika Karbhari
Efficacy and Safety of Vamorolone Over 48 Weeks in Boys With Duchenne Muscular Dystrophy: A Randomized Controlled Trial.
Neurology · 2024 · 70 citations · Paula Clemens
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways.
Cancer discovery · 2023 · 146 citations · Yoshie Umemura
ONC201 (Dordaviprone) in Recurrent H3 K27M-Mutant Diffuse Midline Glioma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 95 citations · Yoshie Umemura
Antioxidant, anti-inflammatory and epigenetic potential of curcumin in Alzheimer's disease.
BioFactors (Oxford, England) · 2024 · 46 citations · Megan Coghlan